Pyrantesan 125 mg/g Proszek do sporządzania roztworu doustnego
Pyrantesan 125 mg/g Proszek do sporządzania roztworu doustnego
Authorised
- Pyrantel tartrate
Product identification
Medicine name:
Pyrantesan 125 mg/g Proszek do sporządzania roztworu doustnego
Active substance:
- Pyrantel tartrate
Target species:
-
Pigeon
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Pyrantel tartrate125.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for oral solution
Withdrawal period by route of administration:
-
In drinking water use
-
Pigeon
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Package description:
- Available only in Polish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Biowet Drwalew Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Drwalewskie Zakłady Przemysłu Bioweterynaryjnego S.A.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1531
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
